Back to 
XTX Topco Ltd
XTX Topco Ltd
AKTX
2 quarters
Position history for XTX Topco Ltd's holdings in AKARI THERAPEUTICS PLC
No. XTX Topco exited its AKTX (Akari Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 49,019 shares worth $14,166. XTX Topco first reported AKTX in Q4 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$14,166
Total Shares Change
-49,019
Quarter-by-Quarter History